首页> 外文OA文献 >Prevalence of drug resistance in patients with pulmonary tuberculosis presenting for the first time with symptoms at chest clinics in India. Part 2. Findings in urban clinics among all patients with or without history of previous chemotherapy
【2h】

Prevalence of drug resistance in patients with pulmonary tuberculosis presenting for the first time with symptoms at chest clinics in India. Part 2. Findings in urban clinics among all patients with or without history of previous chemotherapy

机译:首次出现在印度胸部诊所出现症状的肺结核患者的耐药性患病率。第2部分。所有有或无既往化疗史的患者在城市诊所的调查结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A previous report (Indian Council of Medical Research First Drug ResistanceudInvestigation, 1968) presented the results of a co-operative investigation on the prevalenceudof drug resistance in patients with pulmonary tuberculosis, presenting for theudfirst time with symptoms at chest clinics in India and giving no history of previousudantituberculosis chemotherapy. However, the information obtained from that investigationudis of rather limited value because, in most clinics, fairly large proportions ofudpatients reporting for the first time do so with a history of previous treatment. This isudbecause antituberculosis chemotherapy is offered not only by chest clinics, but also byudgeneral hospitals and private practitioners. In these circumstances, informationudon the prevalence of drug resistance among all patients, irrespective of the history ofudprevious antituberculosis chemotherapy, will be of great value, not only to the cliniciansin-udcharge of the chest clinics but also to those responsible for formulating general policiesudof treatment in the country. The second drug resistance investigation was undertaken
机译:先前的一份报告(印度医学研究委员会首次耐药性 udInvestigation,1968年)介绍了一项合作研究对肺结核患者的耐药性 udud的合作研究结果,首次在胸部诊所呈现症状在印度,也没有既往的抗肺结核化疗史。但是,从该调查中获得的信息的价值相当有限,因为在大多数诊所中,相当大比例的首次报告患者是有既往治疗史的。这是因为因为因为结核诊所不仅提供抗结核化学疗法,而且预算医院和私人执业医师也可以提供。在这种情况下,无论是否有过抗结核化疗史,所有患者中耐药率的信息都将具有重要的价值,不仅对胸部诊所的临床医生,而且对那些负责结核病的医生制定国家的一般政策 udof治疗。进行了第二次耐药性调查

著录项

相似文献

  • 外文文献
  • 专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号